Johnson & Johnson
(MIL:1JNJ)
€
221.15
-4.95 (-2.19%)
Market Cap: 536.59 Bil
Enterprise Value: 565.51 Bil
PE Ratio: 29.35
PB Ratio: 7.52
GF Score: 61/100 Johnson & Johnson at Sanford C Bernstein Strategic Decisions Conference Transcript
Jun 01, 2022 / 02:00PM GMT
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst
All right. Excellent. Well, thanks, everyone, for coming. I'm Lee Hambright, our U.S. medical devices analyst at Bernstein. We are thrilled to have Joaquin Duato, CEO of Johnson & Johnson. We're scheduled for a 50-minute fireside chat. Just a reminder, you can submit questions via the Pigeonhole link.
So Joaquin, first of all, thanks so much for joining us.
Joaquin Duato
Johnson & Johnson - CEO & Director
You're welcome.
Lee Michael Hambright;Joaquin Duato
Sanford C. Bernstein & Co., LLC., Research Division - Analyst;Johnson & Johnson - CEO &
Thanks for being here. You stepped into the CEO role in January, so it's been about 5 months now. I know you've had the opportunity to travel around, spend time with the J&J team and customers around the world. Maybe you could just kick us off with some opening remarks about the state of the business at J&J.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot